Efficacy and Safety of Natalizumab in Crohn’s Disease Patients Treated at 5 Academic Hospitals

Juillerat, P; Wasan, SK; Fowler, SA; Yajnik, V; Korzenik, JR; Pabby, VK; Friedman, S; Coukos, JA; Barto, AE; Pellish, R; and Farraye, FA (2012). Efficacy and Safety of Natalizumab in Crohn’s Disease Patients Treated at 5 Academic Hospitals. Journal of Crohn's & Colitis, 6(Supplement 1), p. 128. Amsterdam: Elsevier

Full text not available from this repository.

Item Type:	Journal Article (Further Contribution)
Division/Institute:	04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Gastroenterology
UniBE Contributor:	Juillerat, Pascal
ISSN:	1873-9946
Publisher:	Elsevier
Language:	English
Submitter:	Factscience Import
Date Deposited:	04 Oct 2013 14:40
Last Modified:	05 Dec 2022 14:12
URI:	https://boris.unibe.ch/id/eprint/16193 (FactScience: 223781)